header bar
  MyelomaLinks - Your Link to the Latest Myeloma News  


MARCH 2009 800.955.4572 Email the IRC Forward to a Friend
 

Welcome to MyelomaLinks, your monthly source of myeloma news, research updates, clinical trials and events of The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit our Patient Services and Disease Information Web sections.

news image

Latest Myeloma News

MRSA Central Line-Related Bloodstream Infections Falling in U.S. Critical Care Units
The rate of methicillin-resistant Staphylococcus aureus (MRSA) central line-associated bloodstream infections in U.S. intensive care units has been dropping, according to a new report. 
::READ MORE NEWS::

LLS Features    ::READ MORE::
.....................................................................................................................................

Research Roundup
   ::READ MORE::
.....................................................................................................................................
IRC Question of the Month  
:: READ MORE::


Inspirational Stories

Inspirational ImageLearn how individuals touched by blood cancer cope. LLS's LifeMosaic Web feature offers hundreds of inspiring stories by patients and families. Read them or submit your own.

Here to Help

For even more information, regularly visit the LLS Web site, www.LLS.org, where many of our education programs are archived free of charge for convenient access 24/7.

If you haven't found what you're looking for in MyelomaLinks , please call our Information Resource Center (IRC) to speak with trained information specialists. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org; or click the "Live Patient Help" button on the www.LLS.org homepage.

Please consider a tax-deductible gift to LLS. Donate online today and help us make a difference in the lives of patients and their families. 

 

Researcher Image

Commentary
Deborah Banker, Ph.D., shares more news on cancer stem cells.

Clinical Trials
We invite you to use our LLS-supported TrialCheck® Web site , a clinical trial search service that offers patients and caregivers immediate access to listings of all myeloma clinical trials. Answer just a few simple questions and a list of available clinical trials related to your cancer will appear in an easy-to-read list of search results. 

You may also want to visit the National Cancer Institute's Cancer Trials Support Unit, providing resources and information on Phase III cancer treatment trials supported by the National Cancer Institute.  ::SELECTED TRIALS::



Newsfeeds & Podcasts

Now you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN UP::

RSS - XML - Podcast - iTunes

Free eNewsletters
Free LLS eNewsletters deliver the latest information on research and treatment options, patient services programs and fundraising events.
::CLICK HERE TO SIGN UP::


bottom bar

Latest Myeloma News
news image

New Effort Brings Industry to Academia
The University of Kansas, with the help of LLS, is using a strategy to find and improve drugs, especially for cancer. 

> Back to the top

LLS Features

calendar image

Two New Promotions Support LLS's Mission

  • Gap Inc's nationwide Give & Get Program will benefit you with a special 30-percent discount coupon good at all Gap, Old Navy and Banana Republic stores. Five percent of all net sales go to LLS. Click here for details. The program ends today.

You can now have an LLS- or TNT-branded VISA credit card, personalized with any image you choose. LLS will receive $50 for each card used plus a percentage of all purchases. Click here for details.

My Personal Clinical Trials Journey
Participate in this personalized and interactive program that follows the stories and experiences of three cancer survivors who have participated in clinical trials.

Co-Pay Assistance Program
Patients with myeloma who have difficulty paying for or simply cannot afford their prescription drug co-pays or health insurance premiums can now apply for up to $5,000 in assistance from LLS.

Archived Educational Events
Experience archived teleconferences and Webcasts free of charge, anytime. Also, a short, easy-to-read summary of the recent program Milestones in Myeloma Therapy: An Update from the American Society of Hematology (ASH) Annual Meeting has been added to the LLS Web site. 

LLS Advocacy
LLS's advocacy team represents the needs of cancer patients and their families in Washington, DC and state capitals throughout the United States. We need your help. Join our Advocates Network and make your voice heard. 

Take Action: Urge Your Representative to Support Blood Cancer Research at the U.S. Department of Defense

Find out about updates to COBRA covered by the Recovery Act signed into law on Feb. 17.
 
Patient Services Survey
Please give us your feedback by completing LLS Disease & Treatment Publications - Survey for Patients, Family and Friends.

LLS Blog


The Leukemia & Lymphoma Society is committed to curing blood cancers and helping patients and their families.
Learn the many ways you can help advance LLS's mission. 

> Back to the top

Research Roundup

links_image_micro2

The proteasome inhibitor bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo  ::READ MORE::

Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation  ::READ MORE::

Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone  ::READ MORE::

The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis  ::READ MORE::

> Back to the top

Clinical Trials
Clinical Trials Image

Selected Trials

Phase II: Carfilzomib in Relapsed and Refractory Multiple Myeloma  ::READ MORE:: 

Phase III: Vorinostat (MK0683) an HDAC Inhibitor or Placebo in Combination with Bortezomib in Patients with Multiple Myeloma  ::READ MORE:: 

Phase III: Melphalan, Prednisone and Thalidomide or Lenalidomide in Treating Patients with Newly Diagnosed Multiple Myeloma  ::READ MORE:: 

Phase III: Lenalidomide and Dexamethasone with or without Bortezomib in Treating Patients with Previously Untreated Multiple Myeloma  ::READ MORE:: 

> Back to the top
IRC Question of the Month: Mouth Sores
Q&A

Q: I am starting chemotherapy for leukemia and I know that painful mouth sores can be a side effect. Is there anything to prevent or treat this?

A: It's great that you're seeking side effects information before starting treatment. Most cancer therapies do affect healthy cells, but side effects can be managed and are usually temporary. Side effects vary, depending on your treatment - discuss the side effects you may experience with your doctor. Together, you can weigh any unwanted effects against the benefits of therapy. Once treatment begins, don't delay to tell your doctor about any side effects you experience and seek help to manage them - don't "tough it out."  

Cells that line the mouth, throat, esophagus, stomach and intestines are sensitive to the effects of chemotherapy and/or radiation therapy. Painful mouth and throat sores called "oral mucositis" can develop as a result of treatment with high-dose chemotherapy and or radiation. Treatment for this side effect is important - to relieve the discomfort or pain it can cause; to ensure that it doesn't interfere with nutrition or oral medication needs; and to manage the risk of infection.  

Drug, mouth care and nutrition approaches are used to prevent or limit the severity of oral mucositis. For some people, treatment includes the drug palifermin (Kepivance®). Palifermin is given intravenously and stimulates the cells lining the mouth and other parts of the digestive tract to grow and develop. Other topical and intravenous agents, are being evaluated for their ability to prevent or treat mucositis.

Mouth care includes use of mouth rinses recommend by the doctor. It's important to avoid mouth washes that contain peroxide or alcohol. Oral mucositis and other side effects of treatment make it a challenge to take in enough calories and protein. Nutrition management is important because both cancer and its treatments increase the body's need for calories and protein.

Nutrition strategies include: 

  • Request pain medication if discomfort is keeping you from eating; soothe your mouth and throat with ice chips (suck, don't chew), Popsicles, ice cream or frozen yogurt.
  • Cook foods until soft or prepare foods in a blender or food processor.
  • Eat high-protein, high-calorie foods to speed healing of the sores or supplement with liquid protein drinks recommended by your doctor; try creamed soups, mashed potatoes, puddings, cooked cereals, served lukewarm or cold.
  • Serve drinks lukewarm or cold and use a straw to bypass mouth sores. Ask you doctor for a complete list of foods and drinks to avoid.

Occasionally, oral mucositis is severe enough to warrant a period of prescribed high-calorie and high-protein supplements with tube or intravenous (IV) feeding until eating and drinking can resume. These forms of therapy may be used to keep patients as healthy and strong as possible during treatment. 

For more information, see Understanding Drug Therapy and Managing Side Effects and Food and Nutrition Facts. Also, see Treatment at www.LLS.org/whattoask for free printable question guides to help you talk to your doctor about side effects and other aspects of treatment.

Please call our Information Resource Center (IRC) to speak with a trained information specialist. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572. Contact us online or click the "Live Patient Help" button on the www.LLS.org homepage.

> Back to the top

Supported by an unrestricted
educational grant from
Cephalon Oncology
Donate Now
Contact Us: The Leukemia & Lymphoma Society, 1311 Mamaroneck Ave., White Plains, NY 10605, (800) 955-4572
Visit our e-Store & Special Offers page where you can support businesses that support LLS.